EUVIMEDEUVIMED entdecken
Crossref

Young Investigator Award

Experimental Animals · 2026 · 75 (Supplement) · S2-S3

DOI: 10.1538/expanim.75suppl-l2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Animals, 2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The objective of this study is to create a risk stratification model for patients in Brunei who would undergo coronary artery bypass graft (CABG) surgery. Materials and Methods: The hospital cardiac surgery database was interrogated and all patients in a 10 year period from 2007 to 2017 who underwent CABG surgery, either as an isolated procedure or together with other concomitant procedures were identified. Their relevant clinical details were then tabulated in a spreadsheet prior to analysis with a statistical package. The relationship between the identifiable patient risk factors and their inpatient mortality was of particular interest in this study.

Results

There were 803 male patients (80.4%) and 196 female patients (19.6%) that made up the total of 999 patients identified from the database that had undergone CABG surgery. From this total, 924 patients had undergone an isolated CABG proce- dure (92.4%) and the remaining 75 patients (7.6%) underwent a CABG with a concomitant procedure. Traditional risk factors such as hypertension, hyperlipidaemia, dia- betes mellitus, smoking status, sex and other variables such as renal insufficiency, intra-aortic balloon pump (IABP) use and urgency of surgery were tested for a statis- tical relationship with in-patient mortality using the chi-square test. All statistically significant variables were then added to our proposed model and evaluated using a series of statistical tests.

Conclusion

Ischaemic heart disease is a major contributor of patient morbidity and mortality in Brunei Darussalam. Despite evolving technologies in the field of inter-ventional cardiology, many patients will still require CABG surgery. In light of this, our study attempts to create a local risk Abstract: Background: Vagal maneuver is a first line treatment for patient with sta- ble supraventricular tachycardia (SVT). Previous study showed prolongation of AH (atrial His) interval in Valsava maneuver. The electrophysiological mechanism of modified Valsava maneuver was not well understood.

Aim

To understand the electrophysiological mechanism of modified Valsava maneu- ver in SVT patient.

Method

Patient with SVT scheduled for electrophysiological study and/or ablation procedure in National Cardiovascular Centre Harapan Kita (NCCHK). SVT was induced in these patients and pre-maneuver data was collected, then standard Valsava and modified Valsava was performed with crossover design. Electrophysiological and hemodynamic data was then analyzed up to 1minute after the maneuvers.

Result

From 16 SVT patients, D AH interval in phase IV of standard Valsava maneuver was 10.6 þ 28.6ms and D AH interval in phase IV of modified Valsava maneuver was 35 þ 27.6ms compared to pre-maneuver data. Significant increase of 24.4 þ 27.6ms (p ¼ 0,003) in D AH interval in phase IV for modified Valsava maneuver was measured compared to standard Valsava maneuver.

Conclusion

Increase vagal response in modified Valsava was shown by prolongation of AH interval compared to standard Valsava maneuver.

Background

A widely accepted technique of graft assessment in coronary artery bypass surgery is transit time flow measurement. This technique is very effective and quick method for intraoperative graft flow assessment in coronary artery bypass grafting. The aim of this study was to assess the patency of the grafts by using Transit Time Flow Meter ( TTFM ) during CABG.

Objectives

To measure the transit time flow meter findings (mean flow and pulsatil-ity index (PI) of the grafts after anastomosis .To determine the immediate outcomes of coronary artery bypass grafting in terms of ejection fraction (EF ) and wall motion by using transoesophageal echocardiogram. To find out the association of TTFM find- ings and outcomes of coronary artery bypass grafting.

Method

This study was hospital based prospective descriptive study who underwent coronary artery bypass surgery only from January 2018 to December 2018.

Result

In this study, total of patients patients and 30ml/min, 30.5% and mean 30ml/min, EF 35% and mean > 30ml/min. Among the patients who did not have wall motion abnormality, 65.2% 22.7% patients mean 30ml/min and 7.6% 30ml/min had wall motion abnormality .1.5% was EF > 35% and PI > 5, was and and patients motion abnormality and 12.1% wall motion abnormality and PI G mutation in the VUS splicing receptor zone of TNNT2 gene responsible for HCM disease in a family with 7 subjects positive with HCM genetic testing.

Conclusion

Half of patients (5/10) were found with HCM-causing mutations, in which three mutations were found in MYH7, one found in MYBPC3, and one found in TNNT2. There was no patient carrying TNNI3 or having more than one of those mutations. All five patients have heterogeneous characteristics with similar genetic muta- tion patterns found in their ten out of 31 family members. For the first time, c.882-2A>G novel mutation in VUS splicing receptor zone of TNNT2 was addressed. Recommendation: Genetic testing should be considered as a test for both patients and their relatives, rather than a test for an individual patient. Our future efforts will focus on demonstrating the whole-genome sequencing and clarifying the early consequences of these mutations to

Zitieren

APA

(2026). Young Investigator Award. Experimental Animals, 75(Supplement), S2-S3. https://doi.org/10.1538/expanim.75suppl-l2

Vancouver

Young Investigator Award. Experimental Animals. 2026;75(Supplement):S2-S3. doi:10.1538/expanim.75suppl-l2

BibTeX
@article{euvimed2026,
  title = {Young Investigator Award},
  journal = {Experimental Animals},
  year = {2026},
  volume = {75},
  number = {Supplement},
  pages = {S2--S3},
  doi = {10.1538/expanim.75suppl-l2}
}
Kostenlos starten →